Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

By Armaganijan Luciana   Patel Dimpi   Dietrich Cristiano   Morillo Carlos A.  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 384-397

MDPI

Access to resources Recommend Favorite

Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders

By Ando Hideya   Matsui Mary S.   Ichihashi Masamitsu  

International Journal of Molecular Sciences, Vol. 11, Iss. 6, 2010-06 ,pp. : 2566-2575

MDPI

Access to resources Recommend Favorite

Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575

By Ando Hideya   Matsui Mary S.   Ichihashi Masamitsu  

International Journal of Molecular Sciences, Vol. 11, Iss. 7, 2010-07 ,pp. : 2699-2700

MDPI

Access to resources Recommend Favorite

Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke

By Kikuchi Kiyoshi   Tancharoen Salunya   Ito Takashi   Morimoto-Yamashita Yoko   Miura Naoki   Kawahara Ko-ichi   Maruyama Ikuro   Murai Yoshinaka   Tanaka Eiichiro  

International Journal of Molecular Sciences, Vol. 14, Iss. 9, 2013-09 ,pp. : 18899-18924

MDPI

Access to resources Recommend Favorite

Combinations of Drugs in the Treatment of Obesity

By Halpern Bruno   Oliveira Eduardo S. L.   Faria André M.   Halpern Alfredo   de Melo Maria Edna   Cercato Cintia   Mancini Marcio C.  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-07 ,pp. : 2398-2415

MDPI

Access to resources Recommend Favorite